Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051597
Status:
COMPLETED
Last Update Posted:
2011-10-12
First Post:
2003-01-13
Brief Title:
A SafetyEfficacy Study of SGN-30 Antibody in Patients With Refractory or Recurrent CD30 Hematologic Malignancies
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hodgkin Disease |
| Lymphoma Large-Cell |
| Sarcoma Kaposi |
| Lymphoma T-Cell Cutaneous |
| Lymphoma B-Cell |
Keywords: